Seegene (Korea) Performance

096530 Stock  KRW 23,150  50.00  0.22%   
The entity has a beta of 0.28, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Seegene's returns are expected to increase less than the market. However, during the bear market, the loss of holding Seegene is expected to be smaller as well. At this point, Seegene has a negative expected return of -0.16%. Please make sure to validate Seegene's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if Seegene performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Seegene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Total Cashflows From Investing Activities-102.7 B
  

Seegene Relative Risk vs. Return Landscape

If you would invest  2,575,077  in Seegene on August 29, 2024 and sell it today you would lose (260,077) from holding Seegene or give up 10.1% of portfolio value over 90 days. Seegene is generating negative expected returns and assumes 2.0993% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than Seegene, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Seegene is expected to under-perform the market. In addition to that, the company is 2.72 times more volatile than its market benchmark. It trades about -0.08 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.17 per unit of volatility.

Seegene Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Seegene's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Seegene, and traders can use it to determine the average amount a Seegene's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0755

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns096530

Estimated Market Risk

 2.1
  actual daily
18
82% of assets are more volatile

Expected Return

 -0.16
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average Seegene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Seegene by adding Seegene to a well-diversified portfolio.

Seegene Fundamentals Growth

Seegene Stock prices reflect investors' perceptions of the future prospects and financial health of Seegene, and Seegene fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Seegene Stock performance.

About Seegene Performance

By analyzing Seegene's fundamental ratios, stakeholders can gain valuable insights into Seegene's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Seegene has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Seegene has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Seegene, Inc. manufactures and sells molecular diagnostics systems. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea. SEEGENE is traded on Korean Securities Dealers Automated Quotations in South Korea.

Things to note about Seegene performance evaluation

Checking the ongoing alerts about Seegene for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Seegene help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Seegene generated a negative expected return over the last 90 days
About 31.0% of the company shares are owned by insiders or employees
Evaluating Seegene's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Seegene's stock performance include:
  • Analyzing Seegene's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Seegene's stock is overvalued or undervalued compared to its peers.
  • Examining Seegene's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Seegene's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Seegene's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Seegene's stock. These opinions can provide insight into Seegene's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Seegene's stock performance is not an exact science, and many factors can impact Seegene's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Seegene Stock analysis

When running Seegene's price analysis, check to measure Seegene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seegene is operating at the current time. Most of Seegene's value examination focuses on studying past and present price action to predict the probability of Seegene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seegene's price. Additionally, you may evaluate how the addition of Seegene to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges